Survival impact of followup care after radical cystectomy for bladder cancer

Journal of Urology

Volumn 190, Issue 5, 2013, Pages 1698-1703

  Strope, Seth A ^a   Chang, Su Hsin ^b   Chen, Line ^b   Sandhu, Gurdarshan ^a   Piccirillo, Jay F ^b   Schootman, Mario ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Cystectomy; Medicare; SEER program; Survival analysis; Urinary bladder neoplasms

Indexed keywords

AMBULATORY CARE; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CYSTECTOMY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH SERVICE; HOSPITAL READMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICARE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; URINALYSIS;

EID: 84888638409     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.05.051     Document Type: Article

References (30)

1. Kuroda M, Meguro N, Maeda O et al: Stage specific follow-up strategy after cystectomy for carcinoma of the bladder. Int J Urol 2002; 9: 129.
2. Madersbacher S, Hochreiter W, Burkhard F et al: Radical cystectomy for bladder cancer todayda homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 21: 690.
3. Raj GV, Bochner BH, Serio AM et al: Natural history of positive urinary cytology after radical cystectomy. J Urol 2006; 176: 2000.
4. Solsona E, Iborra I, Rubio J et al: Late oncological occurrences following radical cystectomy in patients with bladder cancer. Eur Urol 2003; 43: 489.
5. Volkmer BG, Kuefer R, Bartsch GC Jr et al: Oncological followup after radical cystectomy for bladder cancerdis there any benefit? J Urol 2009; 181: 1587.
6. Sanderson KM, Cai J, Miranda G et al: Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. J Urol 2007; 177: 2088.
7. Clark PE, Agarwal N, Biagioli MC et al: Bladder cancer. In: NCCN Clinical Practice Guidelines in Oncology. Fort Washington, Pennsylvania: National Comprehensive Cancer Network 2012.
8. Meissner C, Giannarini G, Schumacher MC et al: The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol 2007; 178: 2287.
9. Stein JP, Lieskovsky G, Cote R et al: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666.
10. Dalbagni G, Bochner BH, Cronin A et al: A plea for a uniform surveillance schedule after radical cystectomy. J Urol 2011; 185: 2091.
11. Fritz A, Jack A and Parkin DM: International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization 2000.
12. Gore JL, Litwin MS, Lai J et al: Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 2010; 102: 802.
13. Gore JL, Lai J, Setodji CM et al: Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer 2009; 115: 988.
14. Brown ML, Riley GF, Schussler N et al: Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care, suppl., 2002; 40: IV-104.
15. Earle CC, Nattinger AB, Potosky AL et al: Identifying cancer relapse using SEER-Medicare data. Med Care, suppl., 2002; 40: IV-75.
16. Rosenbaum PR and Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41.
17. Klabunde CN, Legler JM, Warren JL et al: A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 2007; 17: 584.
18. Xian Y, Holloway RG, Chan PS et al: Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA 2011; 305: 373.
19. Tan HJ, Norton EC, Ye Z et al: Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 2012; 307: 1629.
20. Wooldridge JM: Introductory Econometrics: A Modern Approach. Mason, Ohio: Cengage Learning- 2009.
21. Stock JH, Wright JH and Yogo M: A survey of weak instruments and weak identifications in generalized method of moments. J Bus Econ Stat 2002; 20: 518.
22. Angrist JD, Imbens G and Rubin DB: Identification of causal effects using instrumental variables. J Am Stat Ass 1996; 91: 444.
23. Newey WK: Efficient estimation of limited dependent variable models with endogenous explanatory variables. J Econometr 1987; 36: 231.
24. Blundell RW and Smith RJ: Estimation in a class of simultaneous equation limited dependent variable models. Rev Econ Stud 1989; 56: 37.
25. Terza JV, Basu A and Rathouz PJ: Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ 2008; 27: 531.
26. Mullahy J: Specification and testing of some modified count data models. J Econometr 1986; 33: 341.
27. Cameron AC and Pravin K: Microeconometrics: Methods and Applications. New York: Cambridge University Press 2005.
28. Giannarini G, Kessler TM, Thoeny HC et al: Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 2010; 58: 486.
29. Boorjian SA, Tollefson MK, Cheville JC et al: Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival. J Urol 2011; 186: 1796.
30. Jemal A, Siegel R, Xu J et al: Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277.